logo
Select company
Select metric
$ 176.42MGross Profit
VS
Market
47
Sector
75
Industry
89
History
100
$ 7.51Close
$ 5.8 - $ 16.39 52-Week Range
Ticker Information

Ticker

DAWN

Company Name

DAY ONE BIOPHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

DAY ONE BIOPHARMACEUTICALS INC - Gross Profit Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

DAWN - GP Historical data
DateGross Profit
6/30/2025$ 176.42M
3/31/2025$ 153.76M
12/31/2024$ 125.88M
9/30/2024$ 99.66M
6/30/2024$ 7.49M
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • DAY ONE BIOPHARMACEUTICALS INC's latest trailing twelve months (TTM) GP stands at $ 0.
  • Over the past 5 years, DAY ONE BIOPHARMACEUTICALS INC's average GP has been $ 35.2M.
  • The median GP for DAY ONE BIOPHARMACEUTICALS INC during this period was $ 0
  • DAY ONE BIOPHARMACEUTICALS INC reached its highest GP over the past 5 years at $ 176.42M.
  • The lowest GP recorded by DAY ONE BIOPHARMACEUTICALS INC in the same timeframe $ 0

DAY ONE BIOPHARMACEUTICALS INC's GP vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

GP Benchmarks
CompanyGP
STOK : STOKE THERAPEUTICS INC $ 199.89MAKBA : AKEBIA THERAPEUTICS INC $ 151.66MDNA : GINKGO BIOWORKS HOLDINGS INC $ 182.32MGERN : GERON CORP $ 160.81MMRVI : MARAVAI LIFESCIENCES HOLDINGS INC $ 62.83MKROS : KEROS THERAPEUTICS INC $ 232.84MNAGE : NIAGEN BIOSCIENCE INC $ 73.99MPHAT : PHATHOM PHARMACEUTICALS INC $ 99.11MANAB : ANAPTYSBIO INC $ 123.16MXNCR : XENCOR INC $ 146.93M

Definition of Gross Profit

[Income Statement] Gross Profit is a financial metric that demonstrates how sales [Revenue] cover the direct costs associated with the production of goods [CoR].

DAWN - Gross Profit, Last 5 years

$ 0

Minimum

Dec 31, 2020

$ 176.42M

Maximum

Jun 30, 2025

$ 35.2M

Average

$ 0

Median

GP Benchmark Analysis

The chart above depicts the distribution of GP for companies in the Total Stock Market. The average GP of the companies is $ 245.13M with a standard deviation of $ 328.2M.
The following table provides additional summary stats:
GP in the Market:
filtered constituents3.34K
min$ -790.38M
max$ 1.32B
average$ 245.13M
median$ 92.73M
std$ 328.2M